Assessing Genomic Testing’s Impact on Prostate Cancer (Video)

Genomic testing is increasingly impacting prostate cancer diagnosis and treatment, helping clinicians make more informed management decisions based on the specific molecular characteristics of an individual patient’s cancer. In a video interview, Eric A. Klein, MD, Chairman of Cleveland Clinic’s Glickman Urological & Kidney Institute, discusses the broadening use of molecular-based tests.

Study Finds Safety, Survival Improvements with Modern IMRT for Recurrent Head and Neck Cancer

For patients with head and neck cancer, a new study shows that the safety of modern IMRT re-irradiation appears significantly improved compared with previous re-irradiation results, with prolonged survival in carefully selected patients. The results may alter the common clinical perception that the risks of re-irradiation outweigh its value, and should help guide therapeutic decision-making.